Swiss Stem Cell Foundation, Lugano, Switzerland.
J Cardiovasc Transl Res. 2011 Apr;4(2):192-9. doi: 10.1007/s12265-010-9232-4. Epub 2010 Oct 30.
The 2010 edition of the Lugano Stem Cell Meeting, under the auspices of the Swiss center of excellence in cardiovascular diseases "Cardiocentro Ticino" and the Swiss Stem Cell Foundation, offered an update on clinical, translational, and biotechnological advances in regenerative science and medicine pertinent to cardiovascular applications. Highlights from the international forum ranged from innate mechanisms of heart repair, safety, and efficacy of ongoing and completed clinical trials, novel generations of stem cell biologics, bioengineered platforms, and regulatory processes. In the emerging era of regenerative medicine, accelerating the critical path from discovery to product development will require integrated multidisciplinary teams to ensure timely translation of new knowledge into validated algorithms for practice adoption.
2010 年卢加诺干细胞会议在瑞士心血管疾病卓越中心“Cardiocentro Ticino”和瑞士干细胞基金会的赞助下召开，会议提供了与心血管应用相关的再生科学和医学领域中临床、转化和生物技术进展的最新信息。国际论坛的重点内容涵盖了心脏修复的内在机制、正在进行和已完成的临床试验的安全性和有效性、新一代干细胞生物制剂、生物工程平台和监管流程。在再生医学的新兴时代，需要整合多学科团队来加速从发现到产品开发的关键路径，以确保及时将新知识转化为实践采用的经过验证的算法。
